LNTH News and Press, Lantheus Holdings Inc. From 04/29/22

Lantheus press release (NASDAQ:LNTH): Q1 Non-GAAP EPS of $0.97 beats by $0.51. Revenue of $208.9M (+125.8% Y/Y) beats by $43.6M. Guidance: 2Q22 Revenue between $200M-$215M vs consensus $178.95M. Adj. EPS between $0.67-$0.73 vs consensus of $0.50 FY22 Revenue between $800M-$835M vs consensus $...

Worldwide revenue of $208.9 million for the first quarter 2022, representing an increase of 125.8% from the prior year period GAAP net income of $43.0 million for the first quarter 2022, compared to GAAP net income of $9.0 million in the prior year period GAAP fully dilu...

Lantheus (NASDAQ:LNTH) is scheduled to announce Q1 earnings results on Friday, April 29th, before market open. The consensus EPS Estimate is $0.46 (+820.0% Y/Y) and the consensus Revenue Estimate is $165.3M (+78.7% Y/Y). Over the last 2 years, LNTH has beaten EPS estimates 88% of the time and...

AB,ABBV,AON,ARCB,AZN,B,OTCQX:BASFY,BBVA,BCPC,BLMN,BMY,CBOE,CHTR,CL,COWN,CRI,CVEO,CVX,OTCPK:DNNGY,GTLS,HE,HON,IMO,LHX,LNTH,LYB,MGA,NMRK,NVT,NWG,NWL,PSX,SLCA,SYNH,SYNH,TAL,TRP,WETF,WIT,WPC,WY,XOM For Seeking Alpha's full earnings season calendar, click here. For further details see: ...

NORTH BILLERICA, Mass., April 15, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Friday, April 29, 2022, to discuss its financial and operating results for t...

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Small cap stocks had a rough ride during the first quarte...

Lantheus Holdings reported a strong beat on their fourth-quarter and full-year 2021 earnings. PYLARIFY pulled in over $35M in Q4 and is ready for continued growth in 2022. Lantheus expects 2022 to be a record year and has set their revenue guidance at 685M - $710M, which dwarfs the St...

NORTH BILLERICA, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Fi...

NORTH BILLERICA, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Fi...

Gainers: BiondVax Pharmaceuticals (BVXV) +39%. Alpha Tau Medical (DRTS) +38%. CollPlant Biotechnologies (CLGN) +10%. Aptevo Therapeutics (APVO) +8%. HOOKIPA Pharma (HOOK) +8%. Losers: Sonendo (SONX) -11%. Creative Medical Technology (CELZ) -9%. Lan...